Correlation Between Zynerba Pharmaceuticals and Corbus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zynerba Pharmaceuticals and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zynerba Pharmaceuticals and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zynerba Pharmaceuticals and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Zynerba Pharmaceuticals and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zynerba Pharmaceuticals with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zynerba Pharmaceuticals and Corbus Pharmaceuticals.

Diversification Opportunities for Zynerba Pharmaceuticals and Corbus Pharmaceuticals

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zynerba and Corbus is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Zynerba Pharmaceuticals and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Zynerba Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zynerba Pharmaceuticals are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Zynerba Pharmaceuticals i.e., Zynerba Pharmaceuticals and Corbus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Zynerba Pharmaceuticals and Corbus Pharmaceuticals

If you would invest  36.00  in Zynerba Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Zynerba Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.79%
ValuesDaily Returns

Zynerba Pharmaceuticals  vs.  Corbus Pharmaceuticals Holding

 Performance 
       Timeline  
Zynerba Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zynerba Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zynerba Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Corbus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Corbus Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Zynerba Pharmaceuticals and Corbus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zynerba Pharmaceuticals and Corbus Pharmaceuticals

The main advantage of trading using opposite Zynerba Pharmaceuticals and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zynerba Pharmaceuticals position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.
The idea behind Zynerba Pharmaceuticals and Corbus Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets